synthetic protein consisting of tne N-terminal 290 amino acids of human GPIbalpha with two gain-of-function mutations (G233V/M239V) fused to human IgG1Fc; von Willebrand factor antagonist prevents coronary thrombosis without prolongation of bleeding time
